Purchase Order 75N93024P00021

Award Date 11/24/23
Potential Completion Date 11/23/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cordova, TN 38016, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $21,020 purchase order to Transnetyx, Inc., doing business as Harmonyx Diagnostics, located in Cordova, Tennessee. The firm fixed price contract is for murine fecal sample testing services and runs from August 2024 through August 2025. As part of its mission to advance science and improve public health, the NIH/NIAID frequently contracts for laboratory testing...
This federal contract award to Transnetyx, Inc. (a for-profit organization) provides $19,440.00 for the renewal of an Artificial Mouse Intelligence Software solution. The award, issued by the National Institute of Allergy and Infectious Diseases (a civilian agency within the Department of Health and Human Services), is a firm-fixed-price Purchase Order with a completion date of November 23, 2025. The contract does not have a set-aside designation, indicating that Transnetyx competed in the...
Transnetyx, Inc., doing business as Harmonyx Diagnostics, has been awarded a $1.1 million firm fixed price delivery order contract by the National Institutes of Health's National Institute of Environmental Health Sciences to provide animal genotyping services. Under the terms of the contract, Harmonyx Diagnostics will genotype laboratory animals for NIH-funded research studies over a five year period of performance ending in September 2026. The work will be conducted at Harmonyx Diagnostics'...
The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $5,000 firm fixed price blanket purchase agreement call contract to Transnetyx, Inc., doing business as Harmonyx Diagnostics, located in Cordova, Tennessee. Under this contract, Harmonyx Diagnostics will provide sequencing services to the agency through October 31, 2023 in support of the NIH's research efforts. As the prime contractor on this contract,...
The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $6,268 firm fixed price blanket purchase agreement call contract to Transnetyx, Inc., doing business as Harmonyx Diagnostics, located in Cordova, Tennessee. Under the contract, Harmonyx Diagnostics will provide sequencing services to NIH to support its research efforts. As the prime contractor, Harmonyx Diagnostics will leverage its expertise in genomic...
The U.S. Food and Drug Administration (FDA) awarded a $115,600.00 firm fixed-price purchase order contract to Transnetyx, Inc. for the development and deployment of an Automated Breeding Optimization Application - Artificial Mouse Intelligence (AMI) software system. The contract has an ultimate completion date of September 17, 2028. Transnetyx, a for-profit organization specializing in DNA extraction, gene analysis, and genotyping services, has established a strong track record of supporting...
This is a firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute, a component of the U.S. Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization based in Cordova, Tennessee. The $773,188.55 contract is to provide DNA extraction and multi-gene analysis services for rodent tissue samples to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The contract has an ultimate completion date of July 16,...
<p>The National Institutes of Health National Institute on Aging awarded a $298,717.60 delivery order contract to Transnetyx, Inc., doing business as Harmonyx Diagnostics, located in Cordova, Tennessee. The contract is for a NIA Genotyping Outsourcing Project and runs from May 11, 2022 through April 3, 2023. The pricing structure is firm fixed price. Harmonyx Diagnostics will provide genotyping services to support the National Institute on Aging's research efforts under this contract.</p>
Transnetyx, Inc., doing business as Harmonyx Diagnostics, was awarded a $15,000 firm fixed price blanket purchase agreement call contract by the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases. The contract is associated with the TRANSNETYX, INC. indefinite-delivery/indefinite-quantity contract vehicle and calls for genotyping services to be performed at Transnetyx's facility in Cordova, Tennessee over a four year period concluding in October...
This is a federal contract award to Transnetyx, Inc., a for-profit organization, by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract, valued at $267,486.60, is a firm-fixed-price delivery order with a completion date of April 3, 2024. Transnetyx will provide DNA extraction, multi-gene analysis, bioinformatics, and genotyping services to support the NIA's research efforts,...

Transnetyx, Inc., doing business as Harmonyx Diagnostics, has been awarded a $20,645 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to renew artificial mouse intelligence software. The one-year contract, with performance taking place in Cordova, Tennessee, runs from November 24, 2023 through November 23, 2024. No subcontractors or set aside designations were indicated. The National Institute of Allergy and Infectious Diseases supports research on infectious, immunologic and allergic diseases, making continued access to artificial intelligence capabilities relevant to analyzing mouse models likely integral to its work.

Generated 12/18/23, 8:46 PM